David M Scher MD 535 E 70 St STE 550W, New York, NY 10021 (212)6061253 (phone), (212)7742581 (fax)
Education:
Medical School Duke University School of Medicine Graduated: 1993
Procedures:
Hallux Valgus Repair Lower Arm/Elbow/Wrist Fractures and Dislocations Lower Leg/Ankle Fractures and Dislocations Shoulder Surgery
Conditions:
Fractures, Dislocations, Derangement, and Sprains Scoliosis or Kyphoscoliosis
Languages:
English
Description:
Dr. Scher graduated from the Duke University School of Medicine in 1993. He works in New York, NY and specializes in Orthopedic Pediatric Surgery and Orthopaedic Surgery. Dr. Scher is affiliated with Hospital For Special Surgery.
Lancaster General Health PhsyiciansThe Heart Group Of LG Health 217 Harrisburg Ave STE 200, Lancaster, PA 17603 (717)5448300 (phone), (717)5448265 (fax)
Languages:
English Spanish
Description:
Dr. Scher works in Lancaster, PA and specializes in Cardiovascular Disease. Dr. Scher is affiliated with Lancaster General Hospital.
Realtor Magazine 30 Under 30 Profile: David Scher From the Print Magazine Published June 2006 NORTHEAST REGION DAVID SCHER Scher brings new talent into his brokerage by recruiting business-savvy college interns from Boston-area universities. The interns receive course credit and real-world experience.School of hard knocks:�Scher got his start in a similar way, earning his license at 18 and working his way through college at four different companies before opening his own brokerage in June 2005. He passes on to the interns the hard lessons he learned in the early years. "I tell new salespeople that they're going to succeed eventually, but you have to be able to handle rejection," says Scher, who closed $9.5 million in sales last year.The IT factor:�A full-time information technology staffer -- who got his start as an intern -- set up a customized system to feed listings from the MLS to about 20 different real estate Web sites that Scher maintains. Scher participates in MLSs in four other states in order to help clients market homes in the overlapping New England markets. DAVID SCHER, 23 Broker-Owner First Step Realty Boston, MA www.firststepboston.com
Credit Finance Investor Bulk Purchasing HUD Homes Creative Solutions
About:
Biography and Credentials
David Scher's accomplishments as a successful broker include being the #1 seller of HUD Foreclosures in the Boston area (one of seven who specialize in this sector of the local real estate market). This level of productivity has been attained by the combined implementation of a (US898,723, patent formerly pending) state of the art internet based marketing strategy, which goes well beyond the limited conventional advertising tools, such
using only MLS to market Government and Bank Foreclosure properties. Current brokerage operations demand innovative thinking and execution strategies, along with a knowledgeable team, guaranteeing the property cycle from listing to closing will proceed seamlessly in the shortest time possible. As part of being a full service provider to the REO, HUD, and Foreclosure industry David has a qualified team of property preservation professionals capable of completing all necessary tasks and functions required to close the sale.
Scher leverages his brokerage with an in-house IT company. Having a team of specialized computer programmers ensures a competitive advantage by leveraging continuous innovation of database systems and processes that further simplify the conventional real estate transaction, thereby making his firm more attractive to Buyers, Sellers, and Salespersons.
Further credentials include:
- HUD Authorized Broker
- e-Pro Certified, Realtor
- Featured in the June 2006 Cover Article, "30 Under 30" Winner, Realtor Magazine
Mark A. Tracy - Arlington MA Kevin L. Ward - Arlington MA David S. Scher - Hudson MA J. Keith Johnson - Hudson MA
Assignee:
Alkermes Controlled Therapeutics, Inc. - Cambridge MA
International Classification:
A01N 3718
US Classification:
514 2, 514 1, 514724
Abstract:
This invention relates to sustained release compositions, and methods of forming and using said compositions, for the sustained release of biologically active acid-stable or free sulfhydryl-containing proteins, in particular -IFN. The sustained release composition of this invention comprises a biocompatible polymer having dispersed therein a stabilized biologically active acid-stable or free sulfhydryl-containing protein formulation and a nonionic polymer surfactant.
Methods And Compositions For The Targeted Delivery Of Biologically Active Agents
The present invention relates to a sustained release composition for the targeted delivery of biologically active agents to specific tissues and cells. The composition comprises microparticles containing a biocompatible polymer, a water-soluble polymer and a biologically active agent. In one embodiment, the biologically active agent is an antigen or an immunomodulator. In another embodiment, the biologically is a labile agent. The microparticles have a number median diameter of greater than 20 microns upon administration. The water-soluble polymer is present in the sustained released composition in at least about 20% of the dry weight of the microparticle. The sustained release composition provides for the dissolution of the water-soluble polymer of the composition upon hydration, at a much greater rate than the degradation of the biocompatible polymer. This variance is solubility generates pseudo-microparticles which have a number median diameter which is substantially smaller than the size of the administered microparticles. The pseudo-microparticles can be engulfed by antigen presenting cells of the immune system, or absorbed by the Peyers patches in the gut.
Methods And Compositions For The Targeted Delivery Of Biologically Active Agents
The present invention relates to a sustained release composition for the targeted delivery of biologically active agents to specific tissues and cells. The composition comprises microparticles containing a biocompatible polymer, a water-soluble polymer and a biologically active agent. In one embodiment, the biologically active agent is an antigen or an immunomodulator. In another embodiment, the biologically is a labile agent. The microparticles have a number median diameter of greater than 20 microns upon administration. The water-soluble polymer is present in the sustained released composition in at least about 20% of the dry weight of the microparticle. The sustained release composition provides for the dissolution of the water-soluble polymer of the composition upon hydration, at a much greater rate than the degradation of the biocompatible polymer. This variance in solubility generates pseudo-microparticles which have a number median diameter which is substantially smaller than the size of the administered microparticles. The pseudo-microparticles can be engulfed by antigen presenting cells of the immune system, or absorbed by the Peyer's patches in the gut.
Microencapsulation And Sustained Release Of Biologically Active Acid-Stable Or Free Sulfhydryl-Containing Proteins
Mark Tracy - Arlington MA, US Kevin Ward - Arlington MA, US David Scher - Hudson MA, US J. Johnson - Hudson MA, US
Assignee:
Alkermes Controlled Therapeutics, Inc. - Cambridge MA
International Classification:
A61K038/21 A61K009/14
US Classification:
424/486000, 424/085600
Abstract:
This invention relates to sustained release compositions, and methods of forming and using said compositions, for the sustained release of biologically active acid-stable or free sulfhydryl-containing proteins, in particular -IFN. The sustained release composition of this invention comprises a biocompatible polymer having dispersed therein a stabilized biologically active acid-stable or free sulfhydryl-containing protein formulation and a nonionic polymer surfactant. The method of the invention, for forming a composition for the sustained release of biologically active acid-stable or free sulfhydryl-containing protein, in particular -IFN, includes dissolving a polymer in a polymer solvent to form a polymer solution, adding a stabilized biologically active acid-stable or free sulfhydryl-containing protein formulation and a nonionic surfactant to the polymer solution, and then solidifying the polymer to form a polymer matrix containing the stabilized biologically active acid-stable or free sulfhydryl-containing protein formulation, and a nonionic surfactant. The method of using the sustained release composition of the present invention comprises providing a therapeutically effective blood level of biologically active acid-stable or free sulfhydryl-containing protein in a subject for a sustained period by administering to the subject a dose of the sustained release composition described herein.
Mark Tracy - Arlington MA, US Henry Costantino - Brookline MA, US Maria Figueiredo - Somerville MA, US Kevin Ward - Arlington MA, US David Scher - Hudson MA, US
Assignee:
Alkermes Controlled Therapeutics, Inc. - Cambridge MA
International Classification:
A61K009/22 A61K009/14
US Classification:
424/468000, 424/486000
Abstract:
This invention relates to sustained release compositions, and methods of forming and using said compositions, in particular for the sustained release of Follicle Stimulating Hormone (FSH). The sustained release compositions comprise a polymeric matrix of a biodegradable biocompatible polymer and stabilized FSH. The method of the invention for forming a sustained release composition includes, dissolving a biodegradable biocompatible polymer in a polymer solvent to form a polymer solution; adding biologically active stabilized FSH; removing the solvent; and solidifying the polymer to form a polymer matrix containing stabilized FSH dispersed therein. Also described is a method for providing a therapeutically effective amount of stabilized FSH in a patient in need of for a sustained period comprising administering to the patient a dose of the sustained release compositions of the invention. The sustained release composition of FSH can be used to promote maturation of follicles, promote spermatogenesis and to treat fertility disorders.
Method Of Forming Microparticles That Include A Bisphosphonate And A Polymer
Maria Figueiredo - Somerville MA, US Rajesh Kumar - Marlborough MA, US Maura Maloney - Hingham MA, US Kristin Prinn - Somerville MA, US David Scher - Hudson MA, US Gregory Troiano - Weymouth MA, US Thean Yeoh - Foxboro MA, US Stephen Zale - Hopkinton MA, US
Assignee:
Alkermes Controlled Therapeutics, Inc. - Cambridge MA
International Classification:
A61K009/14 A61K009/50 B01J013/02 B01J013/04
US Classification:
424489000, 264004100
Abstract:
Microparticles that include a bisphosphonate and a polymer are produced by a method that includes forming a water-in-oil emulsion by mixing an aqueous solution of the bisphosphonate with a combination of a biocompatible polymer and a polymer solvent. At least one aqueous liquid can be mixed with the water-in-oil emulsion to form a water-in-oil-in-water emulsion and to extract the polymer solvent from the polymer, thereby forming the microparticles. Methods of treating a patient in need of therapy include administering the microparticles described to the patient. In one embodiment, the microparticles are formulated for the sustained release of the bisphosphonate.
Complex Of Trospium And Pharmaceutical Compositions Thereof
David S. Scher - Hudson MA, US Rachel A. Ryznal - North Oxford MA, US Charles D. Blizzard - Westwood MA, US
Assignee:
Alkermes,Inc. - Cambridge MA
International Classification:
A61K 9/14 A61K 31/46 A61P 13/10 A61P 11/00
US Classification:
424489, 514278
Abstract:
The invention is directed to a complex of trospium and saccharin. In one embodiment, the complex is a crystalline form. In another embodiment, the complex is a monohydrate form. The invention also encompasses methods of preparing the the saccharin complex of trospium and to pharmaceutical compositions thereof.
Method For Providing The Mesh Of A Silk Screen At An Angle For Minimizing Moire
William M. Karlyn - Lynnfield MA David A. Scher - Groveland MA
Assignee:
Autoroll Machine Company, LLC - Middleton MA
International Classification:
B41F 1536
US Classification:
1011284
Abstract:
Silk-screens of annular-shape are provided for the silk-screen printing of halftones on compact discs. The silk-screens are rotatably provided in a carrier so that the angle at which moire can be eliminated or at least minimized or localized for the printing of a particular color can be determined. Following the determination of that angle for each of the colors to be printed, the screens are each then provided with photosensitive emulsion, exposed to light, and washed. The silk-screens are then placed in another carrier at the same angle as before determined for the elimination or at least the minimization or localization of moire, this carrier being capable of being placed directly into the nest of a print head of a conventional silk-screen printing machine.
David began his career with American Family 1992 and became President of the D. Webster-Scher agency in 1998. David received his degree in risk Management from... David began his career with American Family 1992 and became President of the D. Webster-Scher agency in 1998. David received his degree in risk Management from the University WI. Madison He went on to receive his Life Underwriters fellowship from the American College. He is a member of the...
Googleplus
David Scher
Work:
Work?
Education:
Drop off
Bragging Rights:
Arggh
David Scher
Work:
Self Employed - Author
David Scher
David Scher
Relationship:
Married
David Scher
David Scher
David Scher
David Scher
News
Going gray at work can be risky for some women, and men
"I don't think a woman in the workplace is going to follow that trend," David Scher, a civil rights attorney in Washington, said with a laugh. "I think women in the workplace are highly pressured to look young. If I were an older working person, the last thing I would do is go gray."
David Scher, an employment attorney with the Employment Law Group, said: This issue was litigated extensively in the airline industry sometime ago. The bottom line is that it is not illegal to discriminate solely on the basis of weight provided the employer has a legitimate business reason.
Date: Apr 05, 2012
Category: Health
Source: Google
'Wonderland,' which started at the Straz, closes on Broadway Sunday
A group of Tampa Bay area investors in Wonderland learned what a risky business Broadway can be. The Knights of Tampa Bay, organized by Hinks Shimberg and David Scher, both trustees of the Straz, raised more than $3 million from about 35 investors for the production.